Trials
Search / Trial NCT06440096

Complete Blood Count-derived Indexes in Inflammatory Modic Changes

Launched by VEYSEL DELEN, MD · May 28, 2024

Trial Information

Current as of February 19, 2025

Completed

Keywords

ClinConnect Summary

Patients and Methods: A total of 48 patients with MCs (type I/type II=24/24) were included in this study. Their demographic, clinical and hematologic characteristics were recorded. A 10 cm Visual Analog Scale (VAS) was used to detect low back pain intensity. Systemic inflammatory biomarkers including NLR, monocyte/lymphocyte (MLR), platelet/lymphocyte (PLR), neutrophil/lymphocyte\*platelet (NLPR), systemic inflammatory index (SII), systemic inflammatory response index (SIRI), and aggregate index of systemic inflammation (AISI) were derived from whole blood cell count.

Keywords: Neutrophil-...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Inclusion criteria were male or female with type I or type II MCs, aged ≥18 and ≤64 years old, and accepted informed consent to participation.
  • Exclusion Criteria:
  • type III MCs and a combination of MCs' types were excluded. In addition, acute low back pain, spinal deformities, inflammatory diseases, cancers, heart diseases, stroke, lactation, pregnancy, psychiatric disorders, and extreme obesity (BMI≥40 kg/m²) were also excluded.

About Veysel Delen, Md

Veysel Delen, MD, is a dedicated clinical trial sponsor with a robust background in medical research and patient care. With a commitment to advancing healthcare through innovative clinical studies, Dr. Delen leads a team focused on developing and evaluating new therapeutic interventions. His expertise spans various medical disciplines, ensuring a comprehensive approach to trial design and execution. Dr. Delen is passionate about improving patient outcomes and contributing to the scientific community, making him a reliable partner in the pursuit of medical advancement.

Locations

şanlıurfa, , Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0